European Journal of Cancer
Volume 45, Issue 17 , Pages 2930-2934, November 2009

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

Sarcoma Unit, Royal Marsden Hospital, Fulham Rd, London SW3 6JJ, UK

Received 21 July 2009; accepted 20 August 2009. published online 22 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00653-4

doi:10.1016/j.ejca.2009.08.016

European Journal of Cancer
Volume 45, Issue 17 , Pages 2930-2934, November 2009

Article Tools